In what circumstances could nondaily preexposure prophylaxis for HIV substantially reduce program costs?

OBJECTIVES: To review the main factors influencing the costs of nondaily oral preexposure prophylaxis (PrEP) with tenofovir (±emtricitabine). To estimate the cost reductions possible with nondaily PrEP compared with daily PrEP for different populations (MSM and heterosexual populations). DESIGN: Sys...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Kate M., Dimitrov, Dobromir, Hughes, James P., Xia, Fan, Donnell, Deborah, Amico, K. Rivet, Bokoch, Kevin, Chitwarakorn, Anupong, Bekker, Linda-Gail, Holtz, Timothy H., Mannheimer, Sharon, Grant, Robert M., Boily, Marie-Claude
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Epidemiology and Social
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854532/
https://www.ncbi.nlm.nih.gov/pubmed/29424774
http://dx.doi.org/10.1097/QAD.0000000000001766

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854532/
https://www.ncbi.nlm.nih.gov/pubmed/29424774
http://dx.doi.org/10.1097/QAD.0000000000001766

Ejemplares similares